Harvard Apparatus Regenerative Technology, Inc. that had been at risk of losing its listing on the Nasdaq Stock Market has been notified it will remain listed on the stock exchange.
This notification came this week that the Holliston company’s stock exceeded $1 a share for 10 days straight and would remain listed. The company’s stock had fallen to a low of $.58 a share in October from a high of $4.32 in March of this year. The stock was trading at $3.25 in early trading Wednesday.
The clinical-stage biotechnology company produces organ implants for life-threatening conditions.
